Amosense Co., Ltd.

As of June 30, 2026, Amosense Co., Ltd. carries a market capitalization of 78.51B, placing it among publicly traded companies globally. Its enterprise value stands at 117.25B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Amosense Co., Ltd.'s next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Amosense Co., Ltd. has 11.72M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.66, and the price-to-book ratio stands at 1.70.

As of June 30, 2026, Amosense Co., Ltd. trades at an EV/EBITDA multiple of 13.76 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.00 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 72.70 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 117.25B versus a market cap of 78.51B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Amosense Co., Ltd. maintains a current ratio of 1.34, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 133.76, indicating elevated leverage, while an interest coverage ratio of 4.68 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Amosense Co., Ltd. posted a negative return on equity (ROE) of -4.55, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.42, reflecting losses generated across the asset base. The company generates approximately 391.08M in revenue per employee across its workforce of 299.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.18 indicates how many times Amosense Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Amosense Co., Ltd. recorded an income tax benefit of -1.34B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -3.36B and -2.02B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Amosense Co., Ltd.'s stock has declined approximately 16.65% over the past 52 weeks. The 50-day moving average sits at 6,459.10, while the 200-day moving average is 11,186.30.

Over the twelve months ended June 30, 2026, Amosense Co., Ltd. generated 116.93B in revenue and converted that into -2.02B in net income, yielding earnings per share of -176.68. EBITDA reached 8.52B, while operating income came in at 1.61B.

As of June 30, 2026, Amosense Co., Ltd. holds 23.18B in cash and equivalents against 61.92B in total debt, resulting in a net debt position of 37.94B. Total book value stands at 46.29B, with working capital of 21.41B providing operational flexibility.

Amosense Co., Ltd. produced 12.84B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.18B in capital expenditures, free cash flow totaled 7.66B - equivalent to 669.37 per share.

Over the twelve months ended June 30, 2026, Amosense Co., Ltd. posted a gross margin of 24.17, reflecting its pricing power and cost economics. The operating margin of 1.38 and net profit margin of -1.73 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 9.99, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 9.01, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Amosense Co., Ltd. shareholders.

As of June 30, 2026, Amosense Co., Ltd. has an Altman Z-Score of 1.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.